Online Database of Chemicals from Around the World

3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone
[CAS# 272778-12-8]

List of Suppliers
Capot Chemical Co., Ltd. China Inquire  
+86 (571) 8558-6718
+86 13336195806
capotchem@gmail.com
sales@capotchem.com
QQ chat
Chemical manufacturer
chemBlink standard supplier since 2006
Simagchem Corporation China Inquire  
+86 13806087780
sale@simagchem.com
Chemical manufacturer since 2002
chemBlink standard supplier since 2008
Nanjing Legend Pharmaceutical & Chemical Co., Ltd. China Inquire  
+86 (25) 8317-2486
sales@legendpharm.com
Chemical manufacturer
chemBlink standard supplier since 2009
Heta Pharm & Chem Co., Ltd. China Inquire  
+86 (571) 8829-8691
sales@hetapharm.com
zhb0309@hotmail.com
Chemical manufacturer
chemBlink standard supplier since 2009
Enantiotech Corporation Limited China Inquire  
+86 (760) 8528-2375
marketing@enantiotech.net
Chemical manufacturer since 2007
chemBlink standard supplier since 2009
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Chemical manufacturer
chemBlink standard supplier since 2010
Xuchang Chenhe Bio-pharmaceutical Tech. Co., Ltd. China Inquire  
+86 (374) 579-3128
+86 15836530076
wxh5168@126.com
wxh5168@163.com
QQ chat
Chemical manufacturer since 2012
chemBlink standard supplier since 2013
Changzhou Yuanda Pharmaceutical Chemical Co., Ltd. China Inquire  
+86 (519) 8398-4084
+86 13776846168
sales@ydpharm.com
QQ chat
Chemical manufacturer since 2012
chemBlink standard supplier since 2014
Complete supplier list of 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone
Identification
Classification API >> Circulatory system medication >> Anti-atherosclerosis
Name 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone
Synonyms (4S)-3-[(2R,5S)-2-[(S)-(4-fluoroanilino)-(4-trimethylsilyloxyphenyl)methyl]-5-(4-fluorophenyl)-5-trimethylsilyloxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one
Molecular Structure CAS # 272778-12-8, 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone, (4S)-3-[(2R,5S)-2-[(S)-(4-fluoroanilino)-(4-trimethylsilyloxyphenyl)methyl]-5-(4-fluorophenyl)-5-trimethylsilyloxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one
Molecular Formula C39H46F2N2O5Si2
Molecular Weight 716.96
CAS Registry Number 272778-12-8
EC Number 848-798-7
SMILES C[Si](C)(C)OC1=CC=C(C=C1)[C@H]([C@@H](CC[C@@H](C2=CC=C(C=C2)F)O[Si](C)(C)C)C(=O)N3[C@H](COC3=O)C4=CC=CC=C4)NC5=CC=C(C=C5)F
Properties
Density 1.2±0.1 g/cm3 Calc.*
Boiling point 748.9±60.0 ºC 760 mmHg (Calc.)*
Flash point 406.7±32.9 ºC (Calc.)*
Index of refraction 1.566 (Calc.)*
Safety Data
Hazard Symbols symbol   GHS07 Warning    Details
Hazard Statements H315-H319-H335-H413    Details
Precautionary Statements P261-P264-P264+P265-P271-P273-P280-P302+P352-P304+P340-P305+P351+P338-P319-P321-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501    Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Chronic hazardous to the aquatic environmentAquatic Chronic4H413
SDS Available
up Discovory and Applicatios
The compound 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone is a complex organic molecule that features a combination of functional groups including oxazolidinone, phenyl, fluorophenyl, silyl, and amino derivatives. This structure indicates its potential use in specialized applications, particularly within the fields of organic synthesis, medicinal chemistry, or materials science.

The compound's primary structure consists of a central oxazolidinone ring system, which is a heterocyclic structure containing both oxygen and nitrogen atoms. Oxazolidinones are known for their stability and are often used in pharmaceutical research due to their ability to interact with biological systems. The stereochemistry of the compound, indicated by the (2R,5S) and (4S) labels, suggests that it possesses chirality, and this feature is important for its interactions with biological receptors or for its potential as a chiral building block in drug synthesis.

Fluorophenyl groups attached to the molecule could provide additional biological activity, as halogenated aromatic compounds are often used to enhance the stability or bioactivity of drugs. The trimethylsilyl (TMS) groups present in the molecule suggest that it may have specific applications in synthetic chemistry, as silyl groups are commonly used to protect sensitive functional groups or to modulate the reactivity of molecules in chemical reactions.

The molecule also contains a significant portion of a pentyl group attached to the oxazolidinone ring, which may influence the compound's solubility and lipophilicity. This structural feature suggests that the compound could have applications where lipophilicity and membrane permeability are important, such as in drug design, where the balance between water solubility and membrane permeability is a critical consideration.

While the precise applications of this particular molecule may be highly specialized, based on its structural complexity, it is plausible to suggest that it could be utilized in the development of pharmaceuticals, particularly in the design of molecules targeting specific receptors or enzymes. The combination of fluorine substituents and the presence of the oxazolidinone ring system could indicate its potential for interactions with biological systems, possibly as an inhibitor or modulator of a specific protein or enzyme. However, detailed experimental studies would be necessary to explore its bioactivity and confirm its potential therapeutic uses.

Given the complexity and the presence of multiple functional groups, the compound could also have applications in materials science, particularly in the creation of novel polymers or materials with specific electronic or mechanical properties. The presence of the trimethylsilyl groups, known for their ability to enhance stability and reactivity, could indicate that the molecule might be useful in synthetic applications involving controlled reactivity or the creation of advanced materials.

In summary, 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone is a highly specialized and structurally complex molecule with potential applications in medicinal chemistry and synthetic organic chemistry. Further studies would be needed to fully explore its biological and chemical properties, but its intricate design suggests possible uses in drug development and advanced material synthesis.
Market Analysis Reports
List of Reports Available for 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone
Related Products
1-[1-(4-Fluorophenyl)ethyl]piperazine hydrochloride  1-[1-(4-Fluorophenyl)ethyl]-4-piperidinamine hydrochloride  N-[1-(4-Fluorophenyl)ethyl]-4-piperidinemethanamine hydrochloride  N-[1-(4-Fluorophenyl)ethyl]-3-piperidinemethanamine hydrochloride  1-[1-(4-Fluorophenyl)ethyl]-4-piperidinol  4-[2-(4-Fluorophenyl)ethyl]-4'-propyl-1,1'-biphenyl  trans-1-[2-(4-Fluorophenyl)ethyl]-4-(4-propylcyclohexyl)benzene  [(3-Fluorophenyl)ethynyl]trimethylsilane  (4S)-3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino](4-hydroxyphenyl)methyl]-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone  (4S)-3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino][4-(phenylmethoxy)phenyl]methyl]-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone  (1S)-1-(4-Fluorophenyl)-3-[(2S,3R)-1-(4-fluorophenyl)-2-(4-hydroxyphenyl)-4-oxo-3-azetidinyl]propyl beta-D-glucopyranosiduronic acid  (3S,4R)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone  (3S,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone  (3R,4S)-1-(4-Fluorophenyl)-3-[(3R)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone  (3S,4R)-1-(4-Fluorophenyl)-3-[(3R)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone  (3S,4R)-rel-1-(4-Fluorophenyl)-3-[(3R)-3-(2-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone  (3R,4S)-1-(3-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone  (3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-[4-(phenylmethoxy)phenyl]-2-azetidinone  4-[2-(2-Fluorophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]pyridine  (3R,4S)-1-(4-Fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-4-(4-hydroxyphenyl)azetidin-2-one